Zydus Wellness
Zydus Wellness Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Zydus Wellness Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Zydus Wellness Ltd trades at a P/E of 81.61× and P/B of 2.82×, against the Consumer Defensive sector median P/E of 33.39×.
Valuation
Profitability
Growth
Financial Health
Zydus Wellness Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Zydus Wellness Ltd, switchable between annual and quarterly views, consolidated or standalone.
Zydus Wellness Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹16,130.75 Cr and reported EPS of ₹6.20.
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 503 | 843 | 1,767 | 1,867 | 2,009 | 2,255 | 2,328 | 2,709 | 3,961 |
| Other Income | 35 | 39 | 11 | 9 | 10 | 5 | 14 | 14 | 6 |
| Total Income | 538 | 882 | 1,778 | 1,876 | 2,020 | 2,260 | 2,342 | 2,723 | 3,967 |
| Cost of Goods Sold (COGS) | 151 | 298 | 779 | 845 | 980 | 1,146 | 1,138 | 1,278 | 1,567 |
| Gross Profit | 352 | 544 | 988 | 1,022 | 1,029 | 1,109 | 1,189 | 1,431 | 2,394 |
| +Operating Expenses | 226 | 370 | 667 | 677 | 684 | 772 | 881 | 1,051 | 1,884 |
| EBITDA | 125 | 174 | 321 | 344 | 345 | 337 | 308 | 380 | 510 |
| +Non-Operating Expenses | 11 | 43 | 122 | -23 | 49 | 31 | 34 | 46 | 204 |
| Profit Before Tax (PBT) | 150 | 171 | 121 | 112 | 306 | 291 | 260 | 359 | 231 |
| +Tax Expense | 13 | -1 | -20 | -7 | -3 | -20 | -7 | 12 | 33 |
| Profit After Tax (PAT) | 134 | 171 | 142 | 119 | 309 | 310 | 267 | 347 | 197 |
| Earnings Per Share (EPS) | 6.85 | 5.87 | 4.92 | 3.73 | 9.68 | 9.76 | 8.39 | 10.90 | 6.20 |
| Diluted Shares Outstanding (Nos.) | 20 | 29 | 29 | 32 | 32 | 32 | 32 | 32 | 32 |
| +Additional Disclosures | 537 | 1,012 | 2,393 | 2,478 | 2,693 | 3,105 | 3,206 | 3,647 | 5,258 |
| Sales Growth % | — | 67.51 | 109.63 | 5.65 | 7.63 | 12.23 | 3.24 | 16.37 | 46.22 |
| YoY Sales Growth % | — | 67.51 | 109.63 | 5.65 | 7.63 | 12.23 | 3.24 | 16.37 | 46.22 |
| Material Cost % | 30 | 35 | 43 | 40 | 44 | 49 | 44 | 44 | 31 |
| Employee Cost % | 11 | 10 | 10 | 9 | 8 | 7 | 8 | 9 | 8 |
| Other Cost % | 34 | 34 | 28 | 28 | 26 | 27 | 30 | 30 | 40 |
| OPM % | 25 | 21 | 18 | 18 | 17 | 15 | 13 | 14 | 13 |
| Tax % | 9 | -0 | -17 | -6 | -1 | -7 | -3 | 3 | 14 |
| Profit Growth % | — | 27.89 | -17.24 | -16.22 | 160.14 | 0.49 | -14.01 | 29.97 | -43.15 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 116 | 162 | 295 | 319 | 321 | 312 | 284 | 351 | 363 |
Zydus Wellness segment analysis: revenue and profit mix.
Disclosed business segments at Zydus Wellness with their share of revenue and profit, switchable between consolidated and standalone reporting.
Zydus Wellness discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Zydus Wellness Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Zydus Wellness Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Zydus Wellness Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Promoter holding of 69.6% indicates strong insider confidence.
Very low debt-to-equity ratio of 0.03 ensures financial stability.
Strong 5-year revenue growth of 26.31% demonstrates consistent top-line expansion.
Diverse product portfolio including Sugar Free, Complan, Everyuth ensures market presence.
Operating profit margin (OPM) of 12.67% reflects efficient cost management.
What can break it.
Latest quarterly profit declined by -13.40%, signaling profitability challenges.
Negative 5-year EPS growth of -14.90% indicates earnings contraction.
Modest profitability ratios. ROE 3.45% and ROCE 6.16% are relatively low.
Elevated P/E ratio of 43.80 suggests premium valuation and higher risk.
Poor 5-year dividend growth rate of -36.82% affects investor returns.
What would change my mind.
Trim if P/E re-rates above 106 (~3.2× the sector multiple of 33.4). The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 55.47. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Zydus Wellness Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Zydus Wellness Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Zydus Wellness Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Zydus Wellness Ltd — derived from the live tape, not yesterday's close.
Zydus Wellness Ltd last traded at ₹506 with an intraday range of ₹500.25–₹508.15 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹506.00| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 525.15 | +19.15 | +3.78% |
| R3 | 517.25 | +11.25 | +2.22% |
| R2 | 512.70 | +6.70 | +1.32% |
| R1 | 509.35 | +3.35 | +0.66% |
| PIVOT | 504.80 | -1.20 | -0.24% |
| CURRENT | 506.00 | — | — |
| S1 | 485.65 | -20.35 | -4.02% |
| S2 | 493.55 | -12.45 | -2.46% |
| S3 | 496.90 | -9.10 | -1.80% |
| S4 | 501.45 | -4.55 | -0.90% |
ZYDUSWELL is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: 501.45 ~ 508.15
Trading Inside opening range
Zydus Wellness Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Zydus Wellness Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Zydus Wellness Ltd stood at 38.2% of traded volume, against a 20-day average of 35.2%.
Zydus Wellness announcements: results, concalls, ratings, M&A.
Filings Zydus Wellness sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Zydus Wellness files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 146 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Zydus Wellness Limited has informed the Exchange about Schedule of meet
Updates
Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
Updates
Zydus Wellness Limited has informed the Exchange regarding 'disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015 ( PIT…
Analysts/Institutional Investor Meet/Con. Call Updates
Zydus Wellness Limited has informed the Exchange about Transcript
Copy of Newspaper Publication
Zydus Wellness Limited has informed the Exchange about Copy of Newspaper Publication
Investor decks & rating reports.
Zydus Wellness insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Zydus Wellness as reported to SEBI — buying and selling signals from the people who know the business best.
Zydus Wellness insider activity below tracks 29 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Rinesh Gajjar | Insider | 12 Mar 2026 | buy | +1.5 K | ₹6.04 L | ₹402.96 |
| Rinesh Gajjar | Insider | 12 Mar 2026 | buy | +1.5 K | ₹6.04 L | ₹402.96 |
| Rinesh Gajjar | Insider | 12 Mar 2026 | buy | +1.5 K | ₹6.04 L | ₹402.96 |
| Rajat Bhargava | Insider | 06 Mar 2026 | buy | +750 | ₹2.87 L | ₹383.14 |
| Rajat Bhargava | Insider | 06 Mar 2026 | buy | +750 | ₹2.87 L | ₹383.14 |
| Punit Adhia | Insider | 06 Mar 2026 | buy | +300 | ₹1.14 L | ₹381.00 |
| Yatin Desai | Insider | 04 Mar 2026 | buy | +500 | ₹1.9 L | ₹379.84 |
| Yatin Desai | Insider | 04 Mar 2026 | buy | +500 | ₹1.9 L | ₹379.84 |
| Vineet Shrivastava | Insider | 02 Mar 2026 | buy | +787 | ₹3.01 L | ₹382.03 |
| Vineet Shrivastava | Insider | 02 Mar 2026 | buy | +787 | ₹3.01 L | ₹382.03 |
Zydus Wellness dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Zydus Wellness has declared, sequenced by announce and record date.
Zydus Wellness corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Zydus Wellness Ltd: business, sector, key facts.
What Zydus Wellness Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Zydus Wellness Ltd operates in the Consumer Defensive, listed as NSE: ZYDUSWELL, BSE: 531335.
Zydus Wellness Limited is a prominent Indian company specializing in the development, manufacturing, marketing, and distribution of a diverse portfolio of health and wellness products. Their operations span the entire value chain, from product conception to reaching consumers both domestically and internationally through exports. The company's extensive product line caters to a wide range of consumer needs and preferences, showcasing a commitment to offering choices within various health and wellness segments.
A significant portion of Zydus Wellness's business focuses on sugar substitutes. Under the Sugar Free brand umbrella (including variants like Sugar Free Gold, Natura, and Green), they offer a variety of products catering to individuals seeking healthier alternatives to traditional sugar. This segment highlights the company's responsiveness to evolving consumer health consciousness and the growing demand for sugar-free options.
Beyond sugar substitutes, Zydus Wellness boasts a strong presence in other key health and wellness categories. Complan, a milk-based health food drink, and Glucon-D, a glucose-based beverage, contribute substantially to their revenue streams, targeting consumers seeking nutritional supplements and energy boosts. Furthermore, their product portfolio includes I'm lite, a blended sugar coated with stevia, presenting another choice in the healthy sweetener market.
The company also holds a significant position in the personal care sector through established brands. Everyuth provides a range of skincare solutions including face washes, masks, and scrubs, while Nycil offers products addressing prickly heat, cooling needs, and hand hygiene. These diverse offerings demonstrate the company’s strategic diversification across related consumer product categories.
Finally, Zydus Wellness's Nutralite brand focuses on a selection of food products designed for health-conscious consumers. Their offerings include various spreads, such as probiotic butter, table spreads, ghee, and cholesterol-free alternatives, along with mayonnaise and chocolate spread. This segment indicates an expansion into the food sector with a health and wellness-oriented approach, aligning with their overall corporate strategy.
Questions investors ask about Zydus Wellness Ltd (ZYDUSWELL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Zydus Wellness Ltd (ZYDUSWELL)?
The current share price of Zydus Wellness Ltd (ZYDUSWELL) is ₹506. Today, the stock has gained by ₹5.65 (1.13%), trading in a range of ₹500.25 to ₹508.15. The stock opened at ₹505 with a trading volume of 1,39,828 shares.
02Is Zydus Wellness Ltd stock a good investment for long-term?
Zydus Wellness Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹16,130.75 crores, P/E ratio of 81.61, ROE of 3.43%, and ROCE of 6.16%. The dividend yield stands at 0.24%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Zydus Wellness Ltd stock?
The 52-week high price of Zydus Wellness Ltd (ZYDUSWELL) is ₹0, while the 52-week low is ₹0. Currently trading at ₹506, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Zydus Wellness Ltd stock at the current price?
Whether to buy Zydus Wellness Ltd stock at ₹506 depends on multiple factors. The stock is currently trading with a P/E ratio of 81.61 and P/B ratio of 2.82. Today's performance shows a gain of 1.13%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Zydus Wellness Ltd and when is the next dividend?
Zydus Wellness Ltd offers a dividend yield of 0.24%, which means for every ₹100 invested at the current price of ₹506, you can expect to receive approximately ₹0.24 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Zydus Wellness Ltd?
Zydus Wellness Ltd's key financial metrics include: P/E Ratio: 81.61, P/B Ratio: 2.82, ROE: 3.43%, ROCE: 6.16%, Dividend Yield: 0.24%, EPS: ₹6.20, Book Value: ₹179.39, and Debt-to-Equity: 54.97. The company's market cap stands at ₹16,130.75 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Zydus Wellness Ltd stock performing today in the market?
Zydus Wellness Ltd stock opened at ₹505 and is currently trading at ₹506, showing a gain of ₹5.65 (1.13%). The intraday high is ₹508.15 and low is ₹500.25. The trading volume stands at 1,39,828 shares, indicating moderate market participation today.
08What is the P/E ratio of Zydus Wellness Ltd and what does it indicate?
Zydus Wellness Ltd has a Price-to-Earnings (P/E) ratio of 81.61, which means investors are willing to pay ₹81.61 for every ₹1 of earnings. With an EPS of ₹6.20, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Zydus Wellness Ltd (ZYDUSWELL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- ADF Foods (ADFFOODS) Share PricePeer
- Bombay Burmah Trading Corporation (BBTC) Share PricePeer
- Mrs Bectors Food Specialities (BECTORFOOD) Share PricePeer
- Bikaji Foods International (BIKAJI) Share PricePeer
- Britannia Industries (BRITANNIA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy